Advertisement

Topics

Theravance Biopharma, Mylan present positive data from multiple studies of Yupelri at 2018 CHEST meeting

17:16 EDT 13 Oct 2018 | PharmaBiz

Theravance Biopharma, Inc and Mylan NV announced that positive new data from multiple studies of Yupelri (revefenacin) inhalation solution were presented at the 2018 CHEST annual meeting, which was held in

Original Article: Theravance Biopharma, Mylan present positive data from multiple studies of Yupelri at 2018 CHEST meeting

NEXT ARTICLE

More From BioPortfolio on "Theravance Biopharma, Mylan present positive data from multiple studies of Yupelri at 2018 CHEST meeting"

Advertisement
Quick Search
Advertisement
Advertisement